GlassScriptPhysician profile
Carl Gaterbaum
NPI 1225180177
$2,967.70
in general payments reported to CMS, 2019-2025
16 companies · $324 in 2025
The $324 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,296 · 2020: $134 · 2021: $519 · 2022: $311 · 2023: $139 · 2024: $245 · 2025: $324.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $687 · Entertainment: $20.14.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $686.82 |
| Entertainment | $20.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb, A Division of Bausch Health US, LLC | $1,213.36 | 2019-2021 | |
| Coopervision INC. | $626.47 | 2019-2025 | Myday Contact Lens, Clariti Contact Lens |
| Alcon Vision LLC | $430.42 | 2019-2025 | Total30, Precision 1 |
| Sun Pharmaceutical Industries INC. | $155.96 | 2021-2025 | Cequa |
| Oyster Point Pharma, INC. | $123.08 | 2022-2024 | Tyrvaya |
| Abb Con-Cise Optical Group LLC | $112.81 | 2019-2025 | Spectacle Lenses, Contact Lens |
| Dompe US, INC. | $80.60 | 2021 | |
| Kala Pharmaceuticals, INC. | $46.31 | 2021-2022 | |
| Novartis Pharmaceuticals Corporation | $42.71 | 2021-2023 | |
| Tarsus Pharmaceuticals, INC. | $32.95 | 2024 | Xdemvy |
| Optos, INC. | $20.14 | 2024 | Oct Ophthalmoscope, Panoramic Ophthalmoscope, Nfc-700 |
| Carl Zeiss Meditec Ag | $19.40 | 2020 | |
| Bausch & Lomb Americas INC. | $19.01 | 2025 | Miebo |
| Abbvie INC. | $16.80 | 2025 | |
| Allergan, INC. | $14.13 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Visioneering Technologies, INC. | $13.55 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Carl Gaterbaum listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.